We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.18B
Cap. Flow %
-24.44%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Sector Composition

Rank Sector Weight
1 Real Estate 14.75%
2 Consumer Staples 11.78%
3 Consumer Discretionary 6.16%
4 Financials 6.01%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
276
CALL
Coca-Cola
KO
$374B
$512K 0.01%
1,000,000
FUR
277
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
$474K 0.01%
+42,500
New +$526K
PRGN
278
DELISTED
PARAGON SHIPPING INC CL A NEW (MHL)
PRGN
$464K 0.01%
+2,114
New +$438K
NES
279
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
$458K 0.01%
20,000
-15,000
-43% -$423K
WELL.PRI
280
DELISTED
Welltower Inc.
WELL.PRI
$434K 0.01%
+7,500
New +$445K
WBA
281
PUT
DELISTED
Walgreens Boots Alliance
WBA
$428K 0.01%
+200,000
New +$10.1M
TWER
282
DELISTED
Towerstream Corporation Common Stock
TWER
$421K 0.01%
7,355
-1,645
-18% -$87.5K
GS icon
283
PUT
Goldman Sachs
GS
$301B
$395K 0.01%
50,000
-21,200
-30% -$3.41M
CCEP icon
284
CALL
Coca-Cola Europacific Partners
CCEP
$47.9B
$380K 0.01%
+200,000
New +$7.62M
WSM icon
285
PUT
Williams-Sonoma
WSM
$29.1B
$380K 0.01%
+400,000
New +$11.6M
BALT
286
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
$367K 0.01%
+75,000
New +$327K
HYG icon
287
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$358K 0.01%
+270,000
New +$24.8M
SGYP
288
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$324K 0.01%
71,929
-105,521
-59% -$473K
RYL
289
PUT
DELISTED
RYLAND GROUP INC
RYL
$322K 0.01%
+158,800
New +$6.11M
MDLZ icon
290
CALL
Mondelez International
MDLZ
$80.1B
$320K 0.01%
+400,000
New +$12.4M
TXMD icon
291
TherapeuticsMD
TXMD
$24.2M
$293K 0.01%
+2,000
New +$242K
ANTH
292
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$291K 0.01%
9,063
-312
-3% -$9.68K
PG icon
293
PUT
Procter & Gamble
PG
$342B
$280K 0.01%
+100,000
New +$7.96M
M icon
294
CALL
Macy's
M
$6.61B
$265K 0.01%
+200,000
New +$9.34M
MERU
295
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
$262K 0.01%
80,000
-55,000
-41% -$214K
MNKD icon
296
CALL
MannKind Corp
MNKD
$1.25B
$223K ﹤0.01%
20,000
RGLS
297
DELISTED
Regulus Therapeutics
RGLS
$220K ﹤0.01%
+194
New +$229K
C icon
298
CALL
Citigroup
C
$224B
$195K ﹤0.01%
385,000
+185,000
+93% +$9.35M
STZ icon
299
CALL
Constellation Brands
STZ
$22.6B
$190K ﹤0.01%
+200,000
New +$10.9M
WY icon
300
CALL
Weyerhaeuser
WY
$18.3B
$188K ﹤0.01%
+175,000
New +$4.95M

Similar funds

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.18B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 15% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.